Cargando…
ATPase copper transporter A, negatively regulated by miR‐148a‐3p, contributes to cisplatin resistance in breast cancer cells
BACKGROUND: Breast cancer is the leading cause of death among women. Cisplatin is an effective drug for breast cancer, but resistance often develops during long term chemotherapy. While the mechanism of chemotherapy resistance is still not fully understood. METHODS: Survival analyses of ATP7A and AT...
Autores principales: | Yu, Ze, Cao, Weifan, Ren, Yuan, Zhang, Qijia, Liu, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240853/ https://www.ncbi.nlm.nih.gov/pubmed/32508020 http://dx.doi.org/10.1002/ctm2.19 |
Ejemplares similares
-
Epidrug Modulated Expression of MiR-152 and MiR-148a Reverse Cisplatin Resistance in Ovarian Cancer Cells: An Experimental In-vitro Study
por: Khajehnoori, Sahel, et al.
Publicado: (2020) -
miR-148 Regulates Mitf in Melanoma Cells
por: Haflidadóttir, Benedikta S., et al.
Publicado: (2010) -
Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer
por: Song, Bin, et al.
Publicado: (2018) -
Hypoxia-Induced miR-148a Downregulation Contributes to Poor Survival in Colorectal Cancer
por: Nersisyan, Stepan, et al.
Publicado: (2021) -
miR-148 family members are putative biomarkers for sepsis
por: Dong, Lei, et al.
Publicado: (2019)